About Elango Genetics
Elango Genetics is a Healthcare company based in Chennai (India) founded in 2019 by N. Thiyagarajan. It provides genomic-based contract research services for clients. It operates on a B2B model. Its Indian entity Elango Genetics Private Limited reported revenue of ₹46.4 Lakh. Its focus areas include Biotechnology, Genomics and Research Services. Its competitors include Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen and 5 more; 6 of its 10 listed competitors have raised funding.
Company details
Elango Genetics operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and research services. Provides genomic-based contract research services for clients. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Chennai, India
- Founders N. Thiyagarajan
- SectorsHealthcare
- Website elangogenetics.com
- Social Facebook
- Legal Name Elango Genetics Private Limited
- Date of Incorporation 07 May, 2019
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹46.4 Lakh
FY 2025 · +15% YoY
- Net Profit₹3.8 Lakh
FY 2025 · 8% margin
- EBITDA₹7.6 Lakh
FY 2025 · 16% margin
Associated legal entities of Elango Genetics
Elango Genetics operates through Elango Genetics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Elango Genetics Private Limited CIN U74999TN2019PTC129144 | Active | 07 May 2019 | Chennai, Tamil Nadu | ₹0.5 Cr | – | 2 | View details |
Board of directors of Elango Genetics Private Limited (Elango Genetics)
Elango Genetics Private Limited is the primary company behind Elango Genetics. The board of Elango Genetics Private Limited currently have 2 directors; the longest-serving is Varalakshmi Theyagarajan, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Varalakshmi Theyagarajan DIN 08445542 | Director | 07 May 2019 | 7 yrs 5 mo | Elango Genetics Private Limited |
| Thiyagarajan Natesa Mudaliar DIN 08445541 | Director | 07 May 2019 | 7 yrs 5 mo | Elango Genetics Private Limited |
People of Elango Genetics
1 people are tracked at Elango Genetics (1 in leadership).
| Name | Role | Group |
|---|---|---|
N. Thiyagarajan | Founder, Director | Leadership |
Complete people profiles for Elango Genetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Elango Genetics
Figures of Elango Genetics Private Limited, the primary company behind Elango Genetics, for FY 2025. Revenue was ₹46.4 Lakh (+15% year on year). Net profit was ₹3.8 Lakh (8% margin). EBITDA was ₹7.6 Lakh (16% margin). Revenue has grown at a compounded annual rate of +8% over three years and +152% over five years.
- ₹46.4 LakhRevenue · FY 2025 · +15% YoY
- ₹3.8 LakhNet profit · 8% margin
- ₹7.6 LakhEBITDA · 16% margin
- ₹10 LakhPaid-up capital
- +8%Revenue CAGR, 3 years
- +152%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Elango Genetics Private Limited are on its company page.
Detailed financial statements for Elango Genetics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Elango Genetics
Elango Genetics has 10 listed competitors in our database, 6 of them funded. They include Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| sourcebioscience.com | 1903 | Nottingham, United Kingdom | – | 273 | Multiple genomic services are provided for analysis and diagnostics. | |
| basecare.cn | 2010 | Suzhou, China | $36.52M | – | NGS-based diagnostic solutions for neonatal screening are developed. | |
| macrogen.com | 1997 | Seoul, South Korea | – | – | Next-generation sequencing and genomics services are provided globally. | |
| mgrc.com.my | 2004 | Kuala Lumpur, Malaysia | – | – | Genome sequencing, analysis, and genetic screening services are provided. | |
| enarabio.com | 2016 | Oxford, United Kingdom | $84.05M | 38 | T-cell interfaces for cancer therapeutics are developed. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. | |
| 20n.com | 2013 | San Francisco, United States | $2.22M | – | Computational tools are developed to engineer microbes for synthetic biology. | |
| clinical-microbiomics.com | 2016 | Horsholm, Denmark | $9.71M | 35 | Meta-genomics platforms and services for microbiome studies are provided. |
Detailed competitors of Elango Genetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Elango Genetics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elango Genetics
Elango Genetics was founded in 2019.
Elango Genetics is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
The primary company behind Elango Genetics, Elango Genetics Private Limited, reported revenue of ₹46.4 Lakh for FY 2025, up 15% year on year.
Elango Genetics operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, focusing on genomic solutions, and research services. Provides genomic-based contract research services for clients. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Elango Genetics's top competitors include Novogene Corporation, Source BioScience and Genewiz.
Elango Genetics operates through Elango Genetics Private Limited.
The legal entities of Elango Genetics currently have 2 directors, including Varalakshmi Theyagarajan, Thiyagarajan Natesa Mudaliar.